Melodiol Global Health (AU:ME1) has released an update.
Melodiol Global Health Limited has informed the market of its recent issuance of new fully paid ordinary shares, which was conducted in compliance with the relevant provisions of the Australian Corporations Act, without the need for a disclosure document. The company reassures investors that all necessary information has been provided and there are no undisclosed details that could affect investment decisions. Melodiol, known for its high-quality cannabis and plant-based health products, continues to focus on expanding its consumer reach and product development.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.
